Vitiligo is an autoimmune condition that depigments patches of skin. Skincare won’t restore pigment. Daily, disciplined SPF on depigmented areas matters more here than in almost any other condition. Barrier care, fragrance-free formulations, and respectful camouflage choices round out a supportive routine that sits underneath whatever your dermatologist is doing for repigmentation.
If you have vitiligo, you have probably read more dramatic skincare content than you needed to. Most of it overpromises. The realistic project for skincare is not repigmentation, which is the dermatology project, but protection and comfort for skin that has lost its built-in UV defence in some areas and not others.
What it is
Vitiligo is an autoimmune condition in which the immune system targets melanocytes, the pigment-producing cells of the skin. The result is patches of skin that have lost colour, often on the face, hands, around joints, body folds, or in segments along a nerve distribution. It affects about 0.5 to 2% of the global population. Onset is most common before age 30. The pattern of loss can be stable for years or progress slowly; some people experience rapid spreading flares.
Depigmented skin still has all its other components: ceramides, collagen, sweat glands. What it lacks is melanin. That single absence has significant consequences for how the skin handles sunlight, scarring, and temperature.
Why it happens
The underlying mechanism is autoimmune. Genetic susceptibility plus environmental triggers (oxidative stress, mechanical trauma, severe sunburns) sets off T-cell mediated melanocyte destruction. People with vitiligo have elevated rates of other autoimmune conditions, particularly autoimmune thyroid disease, type 1 diabetes, alopecia areata, and pernicious anaemia. Screening for these is often appropriate at diagnosis.
The Koebner phenomenon — new patches appearing at sites of skin trauma — is well-documented. Friction from waistbands, repeated scratches, even aggressive exfoliation can trigger new depigmentation in active disease. This is why aggressive skincare is the wrong instinct.
What helps
SPF discipline is non-negotiable. Depigmented skin burns faster, more severely, and is at higher long-term risk of UV damage because it has no melanin protection. SPF 50, broad-spectrum, applied generously, reapplied every two hours during outdoor time, every single day regardless of weather. Mineral filters (zinc oxide, titanium dioxide) often look cleaner on depigmented patches than chemical filters that can leave a slight yellow cast on already-pale skin.
Tinted mineral sunscreens are a quiet hero here. The iron oxides in tinted formulas block visible light, which contributes to oxidative stress in vitiligo, and also blend the look of depigmented patches with surrounding skin. Two birds.
A barrier-supportive routine around SPF. Fragrance-free, gentle, low-foam cleanser. Ceramide and peptide-based moisturiser like our BioCell Renewal Cream. Microbiome support like Microbiome Glow Serum for skin that may have other autoimmune co-involvement. Skip alcohol-heavy toners, fragrance, essential oils, and aggressive scrubs.
Camouflage is a legitimate option, not a confession. Dermablend, Vitiligone, Vichy Dermablend, and similar dedicated cover products are designed to colour-match and stay on through sweat. Self-tanners (DHA-based) can also temporarily tint depigmented areas; they don’t restore pigment, but they reduce visible contrast for events when that matters. Tattoo camouflage (medical micropigmentation) is an option for stable, long-standing depigmentation in cosmetically prominent areas, performed by trained professionals.
The contrarian take
The internet is full of “natural pigmentation” routines involving turmeric pastes, black seed oil, papaya rubs, and ginkgo biloba supplements. Ginkgo has one small trial showing modest stabilisation of progression (not repigmentation) in non-segmental vitiligo. The rest range from useless to actively irritating. Turmeric stains skin temporarily yellow, which sometimes creates the illusion of repigmentation in the short term and disappoints over the long term. Papaya enzymes can produce contact dermatitis. None of these have evidence anywhere near the level of prescription options.
The other trap is over-exfoliation in pursuit of “matching tone.” Vigorous scrubbing of darker surrounding skin to lighten it back toward the depigmented patch is destructive. It produces irritation, increases Koebner risk, and worsens the contrast over time as the irritated areas hyperpigment. The direction of useful intervention is repigmentation of the lighter areas, not depigmentation of the darker ones. (For very widespread, unresponsive vitiligo, dermatology can offer monobenzone-induced depigmentation as a deliberate medical intervention, but this is a serious, irreversible decision made with specialist input, not something to attempt with scrubs.)
When to see a dermatologist
At diagnosis. With any expansion of existing patches. With any new patch. Before starting any home treatment beyond gentle skincare. Dermatology offers narrowband UVB phototherapy (the most studied repigmentation treatment, with response in roughly 50 to 70% of patients on facial and trunk skin), topical calcineurin inhibitors (tacrolimus, pimecrolimus), topical and oral JAK inhibitors (ruxolitinib cream was FDA-approved for non-segmental vitiligo in 2022), excimer laser, and surgical melanocyte grafting for stable disease. These are real, evidence-backed tools. The earlier the conversation, the more options.
Real numbers
The 2022 TRuE-V1 and TRuE-V2 phase 3 trials of ruxolitinib cream 1.5% in non-segmental vitiligo, reported in the New England Journal of Medicine by Rosmarin D et al., found that approximately 30% of patients achieved at least 75% improvement in facial Vitiligo Area Scoring Index at week 24, versus around 8% on vehicle. Narrowband UVB studies report response rates around 50 to 75% on the face and around 30 to 50% on the trunk over six to twelve months of twice-weekly sessions. Hands and feet remain the slowest to respond. Vitiligo affects roughly 1% of the global population, with no strong gender or ethnic predisposition.
FAQ
Can vitiligo spread to my whole body? Some forms progress slowly over years, some stay stable, and a minority become extensive. Active disease is more likely to progress; stable disease often stays put.
Is vitiligo contagious? No. It is autoimmune, not infectious.
Will my children inherit it? Genetic susceptibility increases risk modestly. Most children of people with vitiligo do not develop it.
Can I get a tan to even out my skin? Deliberate tanning is harmful to the surrounding skin and pointless on the depigmented patches, which won’t tan. Tinted SPF and self-tanner do the visual job more safely.
Is vitiligo painful? The patches themselves are not painful. Sunburns on depigmented areas can be severe. Some people experience mild itching at the edges of active patches.
Related reading: SPF essentials, skin of color routines, and autoimmune skin conditions overview. The SPF tag hub gathers more.
Sources
Rosmarin D et al. Two phase 3, randomized, controlled trials of ruxolitinib cream for vitiligo (TRuE-V1 and TRuE-V2). NEJM.org/” rel=”noopener” target=”_blank”>New England Journal of Medicine, 2022. Ezzedine K et al. Vitiligo. The Lancet, 2015. AAD.org/” rel=”noopener” target=”_blank”>American Academy of Dermatology Association. Vitiligo: overview. aad.org, accessed 2026.